Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1977 1
1978 1
1979 3
1980 3
1981 7
1982 2
1983 2
1984 5
1985 6
1986 8
1987 5
1988 7
1989 13
1990 10
1991 7
1992 9
1993 10
1994 12
1995 11
1996 11
1997 15
1998 18
1999 22
2000 6
2001 8
2002 17
2003 10
2004 17
2005 15
2006 21
2007 13
2008 15
2009 14
2010 27
2011 30
2012 41
2013 38
2014 50
2015 57
2016 54
2017 54
2018 55
2019 74
2020 73
2021 85
2022 83
2023 82
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

1,042 results

Results by year

Filters applied: . Clear all
Page 1
Membranous Nephropathy: Core Curriculum 2021.
Alsharhan L, Beck LH Jr. Alsharhan L, et al. Am J Kidney Dis. 2021 Mar;77(3):440-453. doi: 10.1053/j.ajkd.2020.10.009. Epub 2021 Jan 21. Am J Kidney Dis. 2021. PMID: 33487481 Review.
The understanding and management of membranous nephropathy, a common cause of nephrotic syndrome that is more frequently encountered in adults than in children, has rapidly evolved over the past decade. ...Although immunosuppression with alkylating agents combined w …
The understanding and management of membranous nephropathy, a common cause of nephrotic syndrome that is more frequently encou …
Anti-Glomerular Basement Membrane Disease.
McAdoo SP, Pusey CD. McAdoo SP, et al. Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1162-1172. doi: 10.2215/CJN.01380217. Epub 2017 May 17. Clin J Am Soc Nephrol. 2017. PMID: 28515156 Free PMC article. Review.
Copresentation with other kidney diseases such as ANCA-associated vasculitis and membranous nephropathy seems to occur at a higher frequency than would be expected by chance alone, and in addition atypical presentations of anti-GBM disease are increasingly reported. …
Copresentation with other kidney diseases such as ANCA-associated vasculitis and membranous nephropathy seems to occur at a hi …
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group. Dahan K, et al. J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27. J Am Soc Nephrol. 2017. PMID: 27352623 Free PMC article. Clinical Trial.
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals (NCT01508468). ...Eight serious adverse events occurred in each group. During the obser …
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been conducted. We undertook a multicenter, ra …
Molecular Characterization of Membranous Nephropathy.
Sealfon R, Mariani L, Avila-Casado C, Nair V, Menon R, Funk J, Wong A, Lerner G, Hayashi N, Troyanskaya O, Kretzler M, Beck LH Jr. Sealfon R, et al. J Am Soc Nephrol. 2022 Jun;33(6):1208-1221. doi: 10.1681/ASN.2021060784. Epub 2022 Apr 27. J Am Soc Nephrol. 2022. PMID: 35477557 Free PMC article.
BACKGROUND: Molecular characterization of nephropathies may facilitate pathophysiologic insight, development of targeted therapeutics, and transcriptome-based disease classification. Although membranous nephropathy (MN) is a common cause of adult-onset nephrotic syn …
BACKGROUND: Molecular characterization of nephropathies may facilitate pathophysiologic insight, development of targeted therapeutics, and t …
Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.
Dubin RF, Rhee EP. Dubin RF, et al. Clin J Am Soc Nephrol. 2020 Mar 6;15(3):404-411. doi: 10.2215/CJN.07420619. Epub 2019 Oct 21. Clin J Am Soc Nephrol. 2020. PMID: 31636087 Free PMC article. Review.
Studies to date have already made a substantial effect, for example elucidating target antigens in membranous nephropathy, identifying a signature of urinary peptides that adds prognostic information to urinary albumin in CKD, implicating circulating inflammatory pr …
Studies to date have already made a substantial effect, for example elucidating target antigens in membranous nephropathy, ide …
Prediction of biomarkers associated with membranous nephropathy: Bioinformatic analysis and experimental validation.
Han M, Wang Y, Huang X, Li P, Shan W, Gu H, Wang H, Zhang Q, Bao K. Han M, et al. Int Immunopharmacol. 2024 Jan 5;126:111266. doi: 10.1016/j.intimp.2023.111266. Epub 2023 Nov 28. Int Immunopharmacol. 2024. PMID: 38029552 Free article.
Membranous nephropathy (MN), the most prevalent form of nephrotic syndrome in non-diabetic adults globally, is currently the second most prevalent and fastest-increasing primary glomerular disease in China. ...In the subsequent steps, we conducted quantitative real- …
Membranous nephropathy (MN), the most prevalent form of nephrotic syndrome in non-diabetic adults globally, is currently the s …
Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas.
Uffing A, Hullekes F, Riella LV, Hogan JJ. Uffing A, et al. Clin J Am Soc Nephrol. 2021 Nov;16(11):1730-1742. doi: 10.2215/CJN.00280121. Epub 2021 Oct 22. Clin J Am Soc Nephrol. 2021. PMID: 34686531 Free PMC article.
In this review, we focus on specific clinical dilemmas encountered by physicians in managing recurrent glomerular disease by highlighting new insights into the understanding and treatment of post-transplant focal segmental glomerulosclerosis, membranous nephropathy, …
In this review, we focus on specific clinical dilemmas encountered by physicians in managing recurrent glomerular disease by highlighting ne …
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
This was tested in a randomized, open-label controlled trial of 86 patients with primary membranous nephropathy and persistent nephrotic syndrome after six-months observation and assigned 43 each to receive six-month cyclical treatment with corticosteroid and …
This was tested in a randomized, open-label controlled trial of 86 patients with primary membranous nephropathy and persistent …
Toxic Occupational Exposures and Membranous Nephropathy.
Cremoni M, Agbekodo S, Teisseyre M, Zorzi K, Brglez V, Benzaken S, Esnault V, Planchard JH, Seitz-Polski B. Cremoni M, et al. Clin J Am Soc Nephrol. 2022 Nov;17(11):1609-1619. doi: 10.2215/CJN.02930322. Epub 2022 Oct 25. Clin J Am Soc Nephrol. 2022. PMID: 36283759 Free PMC article.
In addition, the predominance of men in membranous nephropathy, classically attributed to biologic or genetic differences between men and women, could also be due to different occupational exposures. To support this hypothesis, we sought to describe the toxic occupa …
In addition, the predominance of men in membranous nephropathy, classically attributed to biologic or genetic differences betw …
Genetics of membranous nephropathy.
Gupta S, Köttgen A, Hoxha E, Brenchley P, Bockenhauer D, Stanescu HC, Kleta R. Gupta S, et al. Nephrol Dial Transplant. 2018 Sep 1;33(9):1493-1502. doi: 10.1093/ndt/gfx296. Nephrol Dial Transplant. 2018. PMID: 29126273 Free PMC article. Review.
An HLA-DR3 association with membranous nephropathy (MN) was described in 1979 and additional evidence for a genetic component to MN was suggested in 1984 in reports of familial MN. ...There are important genetic ethnic differences in MN. Disease outcome is difficult …
An HLA-DR3 association with membranous nephropathy (MN) was described in 1979 and additional evidence for a genetic component …
1,042 results